Pages that link to "Q71263458"
Jump to navigation
Jump to search
The following pages link to Transforming growth factors-beta 1 and beta 2 in serum and urine from patients with bladder carcinoma (Q71263458):
Displaying 21 items.
- Molecular aspects of bladder cancer III. Prognostic markers of bladder cancer (Q34630648) (← links)
- Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family (Q35173073) (← links)
- Current progress of siRNA/shRNA therapeutics in clinical trials (Q36071638) (← links)
- Molecular markers in bladder cancer: a critical appraisal (Q36526271) (← links)
- A list of candidate cancer biomarkers for targeted proteomics (Q37277962) (← links)
- EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo (Q37681730) (← links)
- Evaluation of transforming growth factor-β1 suppress Pokemon/epithelial-mesenchymal transition expression in human bladder cancer cells (Q38905556) (← links)
- Loss of PPM1A expression enhances invasion and the epithelial-to-mesenchymal transition in bladder cancer by activating the TGF-β/Smad signaling pathway (Q38975175) (← links)
- High NF-κB and STAT3 activity in human urothelial carcinoma: a pilot study (Q39267304) (← links)
- Human urothelial carcinomas--a typical disease of the aged: the clinical utility of human chorionic gonadotrophin in patient management and future therapy (Q40840862) (← links)
- Advances in angiogenesis research: relevance to urological oncology (Q41614316) (← links)
- TGF-B1 pathway as biological marker of bladder carcinoma schistosomal and non-schistosomal (Q45824486) (← links)
- Elevated plasma levels of transforming growth factor-beta 1 (TGF-beta 1) in patients with advanced breast cancer: association with disease progression (Q73402753) (← links)
- Changes in detrusor and urinary growth factors according to detrusor function after partial bladder outlet obstruction in the rat (Q73448291) (← links)
- Urine levels of transforming growth factor-beta 1 in children with ureteropelvic junction obstruction (Q73886368) (← links)
- Modulation of the differentiation status of cultured prostatic smooth muscle cells by an alpha1-adrenergic receptor antagonist (Q77798877) (← links)
- Transforming growth factor-beta 1 serum levels in pregnancy and pre-eclampsia (Q77907182) (← links)
- Molecular pathways in bladder cancer (Q81024663) (← links)
- Elevation of serum transforming growth factor-β1 Level in patients with metastatic prostate cancer (Q83169257) (← links)
- Synthesis, biological evaluation and molecular modelling of 2,4-disubstituted-5-(6-alkylpyridin-2-yl)-1H-imidazoles as ALK5 inhibitors (Q90272572) (← links)
- TGF-β and microRNA Interplay in Genitourinary Cancers (Q92012224) (← links)